Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50-65 years

British Journal of Nutrition

Volumn 102, Issue 1, 2009, Pages 160-165

  Burdge, Graham C ^a   Powell, Jonathan ^b   Dadd, Tony ^b   Talbot, Duncan ^b   Civil, Jacqueline ^b   Calder, Philip C ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

Fish oil; Lipoprotein; Postprandial

Indexed keywords

8 ISOPROSTANE; FISH OIL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MACRONUTRIENT; MALE; MEAL; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; POSTPRANDIAL STATE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

AGED; DIETARY SUPPLEMENTS; DINOPROST; FISH OILS; HUMANS; LINEAR MODELS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PARTICLE SIZE; POSTPRANDIAL PERIOD;

EID: 69249221590     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508143550     Document Type: Article

References (37)

1. Schaefer EJ (2002) Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 75, 191-212.
2. Kris-Etherton PM, Harris WS & Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
3. Griffin BA (1999) Lipoprotein atherogenicity: An overview of current mechanisms. Proc Nutr Soc 58, 163-169.
4. Patsch JR, Miesenbock G, Hopferwieser T, et al. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12, 1336-1345.
5. Roche HM & Gibney MJ (1995) Postprandial triacylglycerolaemia- nutritional implications. Prog Lipid Res 34, 249-266.
6. Blackburn P, Cote M, Lamarche B, et al. (2003) Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism 52, 1379-1386.
7. El Harchaoui K, van der Steeg WA, Stroes ES, et al. (2007) Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 49, 547-553.
8. Hsia J, Otvos JD, Rossouw JE, et al. (2008) Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arterioscler Thromb Vasc Biol 28, 1666-1671.
9. Packard CJ & Shepherd J (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17, 3542-3556.
10. Mora S, Szklo M, Otvos JD, et al. (2007) LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192, 211-217.
11. Roche HM & Gibney MJ (2000) Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 71, 232S-237S.
12. Calder PC (2004) n-3 Fatty acids and cardiovascular disease: Evidence explained and mechanisms explored. Clin Sci (Lond) 107, 1-11.
13. Psota TL, Gebauer SK & Kris-Etherton P (2006) Dietary omega-3 fatty acid intake and cardiovascular risk. J Am Coll Cardiol 98, 3I-18I.
14. Harris WS (1996) n-3 Fatty acids and lipoproteins: Comparison of results from human and animal studies. Lipids 31, 243-252.
15. Minihane AM, Khan S, Leigh-Firbank EC, et al. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990-1997.
16. Griffin BA (2001) The effect of n-3 fatty acids on low density lipoprotein subfractions. Lipids 36, Suppl., S91-S97.
17. Hansen JB, Grimsgaard S, Nilsen H, et al. (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Lipids 33, 131-138.
18. Mori TA, Burke V, Puddey IB, et al. (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 1085-1094.
19. Kelley DS, Siegel D, Vemuri M, et al. (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 86, 324-333.
20. Davidson MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27I-33I.
21. Lu GP, Windsor SL & Harris WS (1999) Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem 10, 151-158.
22. Mostad IL, Bjerve KS, Lydersen S, et al. (2008) Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. Eur J Clin Nutr 62, 419-429.
23. Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327-335.
24. Bulow J, Simonsen L, Wiggins D, et al. (1999) Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose. J Lipid Res 40, 2034-2043.
25. Heath RB, Karpe F, Milne RW, et al. (2003) Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J Lipid Res 44, 2065-2072.
26. Burdge GC, Sala-Vila A, West AL, et al. (2007) The effect of altering the 20 : 5n-3 and 22 : 6n-3 content of a meal on the postprandial incorporation of n-3 polyunsaturated fatty acids into plasma triacylglycerol and non-esterified fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 77, 59-65.
27. Burdge GC, Powell J & Calder PC (2006) Lack of effect of meal fatty acid composition on postprandial lipid, glucose and insulin responses in men and women aged 50-65 years consuming their habitual diets. Br J Nutr 96, 489-500.
28. Otvos JD, Jeyarajah EJ & Cromwell WC (2002) Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 90, 22i-29i.
29. Couture P, Otvos JD, Cupples LA, et al. (2000) Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 20, 815-822.
30. Kraus WE, Houmard JA, Duscha BD, et al. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347, 1483-1492.
31. Brousseau ME, Schaefer EJ, Wolfe ML, et al. (2004) Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 350, 1505-1515.
32. Bhalodkar NC, Blum S, Rana T, et al. (2004) Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol 94, 1561-1563.
33. Schaefer EJ, McNamara JR, Tayler T, et al. (2002) Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 90, 689-696.
34. Otvos JD (2002) Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 48, 171-180.
35. Heijmans BT, Beekman M, Houwing-Duistermaat JJ, et al. (2006) Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med 3, e495.
36. Theobald HE, Goodall AH, Sattar N, et al. (2007) Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 137, 973-978.
37. The European Medicines Agency CfPMP (2008) Points to consider on adjustment for baseline covariates. http://www.emea. europa.eu/pdfs/human/ewp/ 286399en.pdf